Table 5 Univariate and multivariate analysis of variables associated with the development of AF

Univariate

Total

(n=141)

HCM-AF

(n=35)

HCM no-AF

(n=106)

OR

(IC 95%)

P value

Sex M (%)

74 (52)

11 (31)

63 (59)

0.31 (0.14-0.7)

0.004*

LVthick(%)

94 (67)

16 (46)

78 (74)

3.3 (1.5-7.3)

0.002*

LAD (%)

58 (41)

25 (71)

33 (31)

5.53 (2.39-12.8)

<0.001*

LAVmax (%)

102 (72)

31 (89)

71 (67)

3.8 (1.2-11.7)

0.013*

LAVmin (%)

60 (43)

27 (77)

33 (31)

7.47 (3.07-18.17)

<0.001*

LAEF<43% echo (%)

50 (35)

25 (71)

25 (24)

8.1 (3.4-19.1)

<0.001*

LACI>43% echo (%)

75 (53)

30 (86)

45 (42)

9.13 (2.92-22.6)

<0.001*

Multivariate

P value

HR

95% CI

LVthick>19.5 mm

0.52

1.9

0.9-3.9

LAD>40.5 mm

0.03

2.5

1.1-5-5

LAEF<43%

0.014

2.9

1.2-6.9

LACI>43%

0.38

1.6

0.6-4.5

Female Sex

0.22

2.38

1.11-5.00